Roche's Xenical European Labeling Does Not Have Breast Cancer Data
Executive Summary
Roche's anti-obesity agent Xenical (orlistat) has been approved in Europe with clean labeling regarding an association with breast cancer observed in clinical trials that has slowed the application in the U.S.